Cargando…
Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction
Low-density lipoprotein (LDL) modified by hypochlorous acid (HOCl) produced by myeloperoxidase (MPO) is present in atherosclerotic lesions, where it is implicated in the propagation of inflammation and acceleration of lesion development by multiple pathways, including the induction of endothelial dy...
Autores principales: | Abdo, Adrian I., Rayner, Benjamin S., van Reyk, David M., Hawkins, Clare L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558469/ https://www.ncbi.nlm.nih.gov/pubmed/28818791 http://dx.doi.org/10.1016/j.redox.2017.08.004 |
Ejemplares similares
-
Low-Density Lipoprotein Modified by Myeloperoxidase in Inflammatory Pathways and Clinical Studies
por: Delporte, Cédric, et al.
Publicado: (2013) -
Human macrophages limit oxidation products in low density lipoprotein
por: Hultén, Lillemor Mattsson, et al.
Publicado: (2005) -
Effects of Myeloperoxidase-Induced Oxidation on Antiatherogenic Functions of High-Density Lipoprotein
por: Kameda, Takahiro, et al.
Publicado: (2015) -
Data on myeloperoxidase-oxidized low-density lipoproteins stimulation of cells to induce release of resolvin-D1
por: Dufour, Damien, et al.
Publicado: (2018) -
The role of the myeloperoxidase-derived oxidant hypothiocyanous acid (HOSCN) in the induction of mitochondrial dysfunction in macrophages
por: Love, Dominic T., et al.
Publicado: (2020)